A Diagnostics & Imaging Week

InforMedix (Rockville, Maryland), creating a new technology platform designed to enable patients to manage chronic illnesses at home, reported plans to use its patented Med-eMonitor System with HIV-positive patients in San Francisco.

The company said it has received a commitment for $149,000 in federal funds for the program, which will be conducted by San Francisco General Hospital and led by David Bangsberg, MD, an expert on medical adherence.

According to Bangsberg: "Without near-perfect adherence, complex anti-retroviral cocktails simply do not work, yet trying to improve adherence to HIV therapy today is like trying to monitor thousands of patients with high blood pressure – but with no equipment."

No Comments